Janus Henderson Group’s Entrada Therapeutics TRDA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $10.2M | Sell |
1,521,281
-600,373
| -28% | -$4.03M | 0.01% | 717 |
|
|
2025
Q1 | $20.3M | Buy |
2,121,654
+41,287
| +2% | +$395K | 0.01% | 570 |
|
|
2024
Q4 | $36M | Buy |
2,080,367
+368,908
| +22% | +$6.39M | 0.02% | 450 |
|
|
2024
Q3 | $27.4M | Buy |
1,711,459
+161,962
| +10% | +$2.59M | 0.01% | 511 |
|
|
2024
Q2 | $22.1M | Buy |
+1,549,497
| New | +$22.1M | 0.01% | 542 |
|